RecruitingNCT07446738

A Study to Investigate the Clinical Outcome and Quality of Life in Chinese Post-operative CRSwNP Patients

PREDICT: A Prospective, Multicenter Real-World Study to Describe the Clinical Outcome and Quality of Life in Chinese CRSwNP Patients

Sponsor

AstraZeneca

Enrollment

200 participants

Start Date

Mar 20, 2026

Study Type

OBSERVATIONAL

Conditions

Chronic Rhinosinusitis With Nasal Polyps

Summary

This is a prospective, multicenter real-world study to describe the postoperative outcomes and quality of life, disease control and characteristics of patients who underwent surgery, as well as economic burden and post-operative treatment patterns in Chinese patients with CRSwNP recurrence.

Eligibility

Inclusion Criteria5

Participant must be 16 years of age or older, at the time of signing the informed consent.
Participants with a documented diagnosis of CRSwNP.
Endoscopic nasal polypectomy is performed during the screening period.
Voluntarily participate and sign the informed consent form as described in A 3.
No history or current psychiatric disorders, with normal cognitive functions including understanding, expression, and orientation.

Exclusion Criteria3

Any significant disease or disorder that the investigator believes may place the patient at risk or may affect the study results or the patient's ability to participate in the study.
Currently participating in an interventional study.
Patients who are unable to independently complete questionnaires due to language barriers or mental status.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREEndoscopic Sinus Surgery (ESS)

This is a standard of care surgical procedure performed according to clinical routine. No experimental treatment or investigational drug is administered as part of this study.